4 ms·
Hmm, https://en.wikipedia.org/wiki/Methylene_blue#Alzheimer%27s https://en.wikipedia.org/wiki/Methylene_blue#Alzheimer%27s : A Phase 3 clinical trial of LMTM (
by pflanze 8y ago
Hmm, https://en.wikipedia.org/wiki/Methylene_blue#Alzheimer%27s https://en.wikipedia.org/wiki/Methylene_blue#Alzheimer%27s :
A Phase 3 clinical trial of LMTM (TauRx0237 or LMT-X), a derivative of methylene blue, failed to show any benefit against cognitive or functional decline in people with mild to moderate Alzheimer’s disease. Disease progression for both the drug and the placebo were practically identical.
- narrator 8y agoThat was news about the 2016 trial. It did significantly better as a monotherapy in the latest trial in 2017[1]. [1] https://content.iospress.com/download/journal-of-alzheimers-disease/jad170560?id=journal-of-alzheimers-disease%2Fjad170560 https://content.iospress.com/download/journal-of-alzheimers-... (pdf)